Primary Category:
Treatment Protocols
Disease Category:
Bladder, Genitourinary
Status:
Closed
A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming with Intradermal BCG Before Intravesical Therapy for BCG-Naïve High-Grade Non-Muscle Invasive Bladder Cancer
NCT#03091660
Eligible for screening study DCP 001
S1602 will permanently close to accrual effective December 15, 2020.
